Todd W. Ridky

4.4k total citations · 2 hit papers
44 papers, 3.2k citations indexed

About

Todd W. Ridky is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Todd W. Ridky has authored 44 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in Todd W. Ridky's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and Melanoma and MAPK Pathways (5 papers). Todd W. Ridky is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and Melanoma and MAPK Pathways (5 papers). Todd W. Ridky collaborates with scholars based in United States, Netherlands and Austria. Todd W. Ridky's co-authors include Paul A. Khavari, David J. Wong, Howard Y. Chang, John T. Seykora, David S. Cassarino, Eran Segal, Helen Liu, Jonathan Leis, Michael D. Gober and Vladimir Ratushny and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Todd W. Ridky

41 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells

2008 527 citations Todd W. Ridky et al. profile →
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma

2012 409 citations Vladimir Ratushny, Michael D. Gober et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Todd W. Ridky

Since Specialization

Citations

This map shows the geographic impact of Todd W. Ridky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd W. Ridky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd W. Ridky more than expected).

Fields of papers citing papers by Todd W. Ridky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd W. Ridky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd W. Ridky. The network helps show where Todd W. Ridky may publish in the future.

Co-authorship network of co-authors of Todd W. Ridky

This figure shows the co-authorship network connecting the top 25 collaborators of Todd W. Ridky. A scholar is included among the top collaborators of Todd W. Ridky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd W. Ridky. Todd W. Ridky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development 2025 ·Cancer Research Communications ·Christopher A. Natale, (unknown), (unknown), (unknown), Israel Olayide, Christopher K. Arnatt, John T. Seykora, Tina Garyantes, Wolfgang Lüke, Todd W. Ridky	0
2	LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway 2023 ·Cancer Research Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christopher A. Natale, (unknown), J. Kevin Foskett, Martin Carroll, Todd W. Ridky	2
3	Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression 2022 ·Nature Communications ·Jaskaren Kohli, Ge Chen, Eleni Fitsiou, (unknown), Simone Brandenburg, William J. Faller, Todd W. Ridky, Marco Demaria	25
4	Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling 2022 ·Science Advances ·(unknown), (unknown), Christopher A. Natale, (unknown), (unknown), Sung Hoon Kim, Yiliang Wei, Christopher R. Vakoc, Brian C. Capell, John A. Katzenellenbogen, Benita S. Katzenellenbogen, Michael E. Feigin, Todd W. Ridky	14
5	Expression of p15 in a spectrum of spitzoid melanocytic neoplasms 2019 ·Journal of Cutaneous Pathology ·(unknown), (unknown), Tzvete Dentchev, Junko Takeshita, Todd W. Ridky, John T. Seykora, Emily Y. Chu	3
6	LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors 2019 ·Cell Reports ·Shaun Egolf, Yann Aubert, (unknown), (unknown), (unknown), (unknown), Jessica Lee, (unknown), (unknown), Yemin Lan, Cory L. Simpson, Todd W. Ridky, Brian C. Capell	54
7	Lysosomes Support the Degradation, Signaling, and Mitochondrial Metabolism Necessary for Human Epidermal Differentiation 2018 ·Journal of Investigative Dermatology ·(unknown), (unknown), Ankit Dahal, Mingen Liu, Vito W. Rebecca, Gregory L. Beatty, Ravi K. Amaravadi, Todd W. Ridky	50
8	Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade 2018 ·eLife ·Christopher A. Natale, Jinyang Li, Junqian Zhang, Ankit Dahal, Tzvete Dentchev, Ben Z. Stanger, Todd W. Ridky	99
9	Selective Vulnerability of Cancer Cells by Inhibition of Ca2+ Transfer from Endoplasmic Reticulum to Mitochondria 2016 ·Cell Reports ·César Cárdenas, Marioly Müller, Andrew S. McNeal, Alenka Lovy, Fabián Jaña, Galdo Bustos, Félix A. Urra, Natalia Smith‐Cortinez, Jordi Molgó, (unknown), Todd W. Ridky, J. Kevin Foskett	209
10	p15 Expression Differentiates Nevus from Melanoma 2016 ·American Journal Of Pathology ·Laura A. Taylor, (unknown), Tzvete Dentchev, (unknown), Emily Y. Chu, Todd W. Ridky, John T. Seykora	12
11	CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma 2015 ·Cancer Discovery ·Andrew S. McNeal, Kevin Liu, (unknown), Christopher A. Natale, Elizabeth K. Duperret, Brian C. Capell, Tzvete Dentchev, Shelley L. Berger, Meenhard Herlyn, John T. Seykora, Todd W. Ridky	64
12	IQGAP1 and IQGAP3 Serve Individually Essential Roles in Normal Epidermal Homeostasis and Tumor Progression 2015 ·Journal of Investigative Dermatology ·(unknown), Andrew S. McNeal, Elizabeth K. Duperret, Seung Ja Oh, Emily S. Lebow, Todd W. Ridky	30
13	Focal adhesion complex proteins in epidermis and squamous cell carcinoma 2013 ·Cell Cycle ·Elizabeth K. Duperret, Todd W. Ridky	26
14	From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma breakdown → 2012 ·Journal of Clinical Investigation ·Vladimir Ratushny, Michael D. Gober, Ryan Hick, Todd W. Ridky, John T. Seykora	409
15	Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia 2007 ·Cancer Research ·Jennifer Zhang, Amy E. Adams, Todd W. Ridky, Shiying Tao, Paul A. Khavari	37
16	Nonmelanoma skin cancer 2007 ·Journal of the American Academy of Dermatology ·Todd W. Ridky	78
17	p63 regulates proliferation and differentiation of developmentally mature keratinocytes 2006 ·Genes & Development ·Amy Truong, Markus Kretz, Todd W. Ridky, Robin A. Kimmel, Paul A. Khavari	402
18	The Plant Lectin Wheat Germ Agglutinin Inhibits the Binding of Pemphigus Foliaceus Autoantibodies to Desmoglein 1 in a Majority of Patients and Prevents Pathomechanisms of Pemphigus Foliaceus In Vitro and In Vivo 2003 ·The Journal of Immunology ·Susana Ortiz‐Urda, Adelheid Elbe‐Bürger, Josef Smolle, (unknown), Yakov Chudnovsky, Todd W. Ridky, (unknown), Klaus Wolff, Klemens Rappersberger	9
19	Drug-Resistant HIV-1 Proteases Identify Enzyme Residues Important for Substrate Selection and Catalytic Rate 1998 ·Biochemistry ·Todd W. Ridky, Alexandra Kikonyogo, Jonathan Leis, Sergei Gulnik, Terry Copeland, John W. Erickson, Alexander Wlodawer, Igor Kurinov, Robert W. Harrison, Irene T. Weber	46
20	Human Immunodeficiency Virus, Type 1 Protease Substrate Specificity Is Limited by Interactions between Substrate Amino Acids Bound in Adjacent Enzyme Subsites 1996 ·Journal of Biological Chemistry ·Todd W. Ridky, Craig E. Cameron, (unknown), Jonathan Leis, Terry Copeland, Alexander Wlodawer, Irene T. Weber, Robert W. Harrison	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact